Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


  1. 2023
  2. Published

    Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Mansouri, L., Thorvaldsdottir, B., Sutton, L. A., Karakatsoulis, G., Meggendorfer, M., Parker, H., Nadeu, F., Brieghel, C., Laidou, S., Moia, R., Rossi, D., Catherwood, M., Kotaskova, J., Delgado, J., Rodríguez-Vicente, A. E., Benito, R., Rigolin, G. M., Bonfiglio, S., Scarfo, L., Mattsson, M. & 41 others, Davis, Z., Gogia, A., Rani, L., Baliakas, P., Foroughi-Asl, H., Jylhä, C., Skaftason, A., Rapado, I., Miras, F., Martinez-Lopez, J., de la Serna, J., Rivas, J. M. H., Thornton, P., Larráyoz, M. J., Calasanz, M. J., Fésüs, V., Mátrai, Z., Bödör, C., Smedby, K. E., Espinet, B., Puiggros, A., Gupta, R., Bullinger, L., Bosch, F., Tazón-Vega, B., Baran-Marszak, F., Oscier, D., Nguyen-Khac, F., Zenz, T., Terol, M. J., Cuneo, A., Hernández-Sánchez, M., Pospisilova, S., Mills, K., Gaidano, G., Niemann, Carsten, Campo, E., Strefford, J. C., Ghia, P., Stamatopoulos, K. & Rosenquist, R., 2023, In: Leukemia. 37, 2, p. 339-347 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut

    Huber, H., Tausch, E., Schneider, C., Edenhofer, S., von Tresckow, J., Robrecht, S., Giza, A., Zhang, C., Fürstenau, M., Dreger, P., Ritgen, M., Illmer, T., Illert, A. L., Dürig, J., Böttcher, S., Niemann, C. U., Kneba, M., Al-Sawaf, O., Kreuzer, K. A., Fink, A. M. & 5 others, Fischer, K., Döhner, H., Hallek, M., Eichhorst, B. & Stilgenbauer, S., 2023, In: Blood. 142, 11, p. 961-972 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

    Eichhorst, B., Niemann, C. U., Kater, A. P., Fürstenau, M., von Tresckow, J., Zhang, C., Robrecht, S., Gregor, M., Juliusson, G., Thornton, P., Staber, P. B., Tadmor, T., Lindström, V., Da Cunha-Bang, C., Schneider, C., Poulsen, C. B., Illmer, T., Schöttker, B., Nösslinger, T., Janssens, A. & 30 others, Christiansen, I., Baumann, M., Frederiksen, H., Van Der Klift, M., Jäger, U., Leys, M. B. L., Hoogendoorn, M., Lotfi, K., Hebart, H., Gaska, T., Koene, H., Enggaard, L., Goede, J., Regelink, J. C., Widmer, A., Simon, F., De Silva, N., Fink, A., Bahlo, J., Fischer, K., Wendtner, C., Kreuzer, K. A., Ritgen, M., Brüggemann, M., Tausch, E., Levin, M., van Oers, M., Geisler, C., Stilgenbauer, S. & Hallek, M., 2023, In: New England Journal of Medicine. 388, 19, p. 1739-1754 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

    Fürstenau, M., Thus, Y. J., Robrecht, S., Mellink, C. H. M., van der Kevie-Kersemaekers, A. M., Dubois, J., von Tresckow, J., Patz, M., Gregor, M., Thornton, P., Staber, P. B., Tadmor, T., Levin, M. D., da Cunha-Bang, C., Schneider, C., Poulsen, C. B., Illmer, T., Schöttker, B., Janssens, A., Christiansen, I. & 27 others, Nösslinger, T., Baumann, M., Hebart, H., Gaska, T., Regelink, J. C., Dompeling, E. C., Lindström, V., Juliusson, G., Widmer, A., Goede, J., Goldschmidt, N., Simon, F., De Silva, N., Fink, A. M., Fischer, K., Wendtner, C. M., Ritgen, M., Brüggemann, M., Tausch, E., Spaargaren, M., Eldering, E., Stilgenbauer, S., Niemann, Carsten, Hallek, M., Eichhorst, B., Kreuzer, K. A. & Kater, A. P., 2023, In: Blood. 142, 5, p. 446–459

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation

    Kielbassa, K., Haselager, M. V., Bax, D. J. C., van Driel, B. F., Dubois, J., Levin, M. D., Kersting, S., Svanberg, R., Niemann, Carsten, Kater, A. P. & Eldering, E., 2023, In: Leukemia. 37, 6, p. 1268-1276 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Immediate COVID-19 treatment in CLL

    Niemann, Carsten, 2023, In: Blood. 141, 18, p. 2167-2168 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  8. Published

    Impact of Minimal Residual Disease on Progression-Free Survival Outcomes after Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study

    Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M. D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, K., Qi, Q., Parisi, L., Srinivasan, S., Schuier, N. & 5 others, Baeten, K., Howes, A., Caces, D. B., Niemann, Carsten & Kater, A. P., 2023, In: Journal of Clinical Oncology. 41, 21, p. 3689-3699 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia

    Rotbain, E. C., Allmer, C., Rostgaard, K., Andersen, M. A., Vainer, N., da Cunha-Bang, C., Parikh, S. A., Rabe, K. G., Hjalgrim, Henrik, Frederiksen, H., Slager, S. L. & Niemann, Carsten, 2023, In: American Journal of Hematology. 98, 8, p. 1236-1245 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours

    Roen, A., Terrones, C., Bannister, W., Helleberg, M., Andersen, M. A., Niemann, Carsten, Daugaard, G., Specht, Lena, Mocroft, A., Reekie, J. & Lundgren, Jens, 2023, In: Infection. 51, 11 p., 147–157.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia

    Vainer, N., Aarup, K., Andersen, M. A., Wind-Hansen, L., Nielsen, T., Frederiksen, H., Enggaard, L., Poulsen, Christian Bjørn, Niemann, Carsten & Rotbain, E. C., 2023, In: British Journal of Haematology. 201, 5, p. 874-886 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...10 Next

ID: 185059285